Geneos Wealth Management’s Express, Inc. EXPR Stock Holding History

Geneos Wealth Management’s Portfolio EXPR Stock Details EXPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17	Closed	–	–	2680
2022 Q2	$0	Hold	17	–	–	﹤0.01%	2832
2022 Q1	$1K	Hold	17	–	–	﹤0.01%	2722
2021 Q4	$1K	Hold	17	–	–	﹤0.01%	2740
2021 Q3	$1K	Hold	17	–	–	﹤0.01%	2808
2021 Q2	$2K	Buy	+17	New	+$1.43K	﹤0.01%	2705

Other funds holding EXPR

Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

USPCM

Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return

Geneos Wealth Management's EXPR Position: Q3 2022 in Review

Geneos Wealth Management sold out of Express, Inc. (EXPR) in Q3 2022, closing a stake of 17 shares.

Geneos Wealth Management first reported a position in EXPR in Q2 2021 and held it in 5 quarters. The position peaked at $2K in Q2 2021. 82 funds tracked by Wall St. Rank hold EXPR as of Q3 2022.

Geneos Wealth Management reported no remaining Express, Inc. position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 17 Express, Inc. shares in Q3 2022.
Geneos Wealth Management first reported a position in Express, Inc. in Q2 2021 and held it in 5 quarters.
Geneos Wealth Management's Express, Inc. position peaked at $2K in Q2 2021.
82 funds tracked by Wall St. Rank held Express, Inc. as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.